Arcadia Biosciences Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
01 Aug 24 | BuyUS$1,442 | Thomas Schaefer | Individual | 700 | US$2.06 | |
01 Aug 24 | BuyUS$1,442 | Mark Kawakami | Individual | 700 | US$2.06 | |
01 Feb 24 | BuyUS$1,442 | Thomas Schaefer | Individual | 700 | US$2.06 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 9,814 | 0.72% |
Institutions | 62,187 | 4.56% |
General Public | 1,290,839 | 94.7% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 22.7%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
25,000 | US$71.0k | 0% | no data | |||
14,038 | US$39.9k | 0% | no data | |||
12,146 | US$34.5k | 0% | no data | |||
8,272 | US$23.5k | -0.54% | no data | |||
5,000 | US$14.2k | 0% | no data | |||
2,119 | US$6.0k | 195% | no data | |||
1,981 | US$5.6k | 0% | no data | |||
1,764 | US$5.0k | -1.07% | no data | |||
607 | US$1.7k | 0% | no data | |||
500 | US$1.4k | 0% | no data | |||
239 | US$678.9 | 0% | no data | |||
214 | US$607.7 | 0% | no data | |||
75 | US$212.9 | 0% | no data | |||
18 | US$51.1 | 0% | no data | |||
11 | US$31.4 | 0% | no data | |||
5 | US$14.3 | 0% | no data | |||
5 | US$14.3 | 0% | no data | |||
4 | US$11.2 | 0% | no data | |||
2 | US$5.8 | 0% | no data | |||
1 | US$2.7 | 0% | no data |